| Financial Year |
March 31 2023 |
| Monetary Funds |
917,318,825.05 |
| Held-for-trading Financial Assets |
376,578,801.62 |
| Notes Receivable |
-- |
| Accounts Receivable |
360,458,461.66 |
| Advances to Suppliers |
48,554,411.95 |
| Other Receivables |
11,353,588.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,008,105,716.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,628,657.66 |
| Total Current Assets |
2,732,998,463.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
796,646,217.49 |
| Under-construction Projects |
103,830,375.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
143,939,545.12 |
| R&D expenses |
-- |
| Goodwill |
68,924,251.89 |
| Long-Term Deferred and Prepaid Expenses |
147,599,034.59 |
| Deferred Income Tax Assets |
8,174,121.37 |
| Other Non-Current Assets |
1,464,244.72 |
| Sub-Total of Non-Current Assets |
1,288,776,906.09 |
| Total Assets |
4,021,775,369.48 |
| Short-Term Loans |
25,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
317,444,202.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,660,166.38 |
| Taxes Payable |
22,765,734.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
110,178,047.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,983,032.99 |
| Other Current Liabilities |
12,737,563.02 |
| Sub-Total of Current Liabilities |
650,046,131.32 |
| Long-term Loans |
132,780,662.88 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,331,952.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
200,759,625.06 |
| Total Liabilities |
850,805,756.38 |
| Paid-In Capital(Or Share Stock) |
414,019,506.00 |
| Capital Surplus |
1,101,824,940.85 |
| Surplus Reserve |
271,042,124.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,275,481,050.73 |
| Minority Stockholder's Interest |
112,136,229.47 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,058,833,383.63 |
| Owner's Equity（Stockholder's Equity） |
3,170,969,613.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,021,775,369.48 |
